UBS initiated coverage of Cross Country Healthcare with a Neutral rating and $22 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CCRN:
- Cross Country price target lowered to $26 from $29 at Barrington
- Cross Country Healthcare downgraded to Hold from Buy at Jefferies
- AMN Healthcare downgraded to Hold from Buy at Jefferies
- Cross Country Healthcare price target lowered to $24 from $31 at Benchmark
- Cross Country Healthcare sees Q4 adjusted EPS 25c-35c, consensus 45c